NuGenerex Immuno-Oncology赞助的临床试验
总计16个结果
-
NuGenerex Immuno-OncologyMerck Sharp & Dohme LLC; NSABP Foundation Inc主动,不招人
-
San Antonio Military Medical CenterNuGenerex Immuno-Oncology; Norwell, Inc.完全的
-
Mural Oncology, IncImmune Oncology Network完全的
-
Immune Oncology Research Institute招聘中
-
Immune Oncology Research Institute招聘中成浆性浆细胞样树突状细胞肿瘤 (BPDCN)美国, 亚美尼亚, 加拿大, 埃及, 乔治亚州, 英国, 塞浦路斯, 意大利, 火鸡, 印度, 伊拉克, 台湾, 科威特
-
NeoImmuneTechImmune Oncology Network终止
-
Tunisian Association for Immuno-oncology Research尚未招聘根据突尼斯的流行病学和生物学概况确定符合免疫治疗条件的患者人数
-
Immune Oncology Research InstituteAgenus Inc.招聘中
-
Immune Oncology Research InstituteAgenus Inc.尚未招聘
-
PrimeVax Immuno-Oncology Inc.Walter Reed Army Institute of Research (WRAIR)尚未招聘
-
PrimeVax Immuno-Oncology Inc.Walter Reed Army Institute of Research (WRAIR)尚未招聘晚期黑色素瘤
-
Tom AppletonWestern University; Canadian Research Group in Immuno-Oncology尚未招聘炎性关节炎 | 免疫相关不良事件
-
University of Wisconsin, MadisonBristol-Myers Squibb; National Cancer Institute (NCI); AnYxis Immuno-Oncology GmbH; Provenance Biopharmaceuticals暂停
-
Assistance Publique - Hôpitaux de ParisCancer Research and Personalized Medicine (Carpem); Laboratoire d'excellence en immuno-oncologie...未知